Načítá se...
Liver depot gene therapy for Pompe disease
Gene therapy for Pompe disease has advanced to early phase clinical trials, based upon proof-of-concept data indicating that gene therapy could surpass the benefits of the current standard of care, enzyme replacement therapy (ERT). ERT requires frequent infusions of large quantities of recombinant h...
Uloženo v:
| Vydáno v: | Ann Transl Med |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6642935/ https://ncbi.nlm.nih.gov/pubmed/31392200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.05.02 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|